BRCA Hereditary Ovarian Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

BRCA Hereditary Ovarian Carcinoma

subtype

Identifier: CI-CAN-00002034
Entity page: /cancer/brca-hereditary-ovarian-carcinoma ↗
Edges: 9

Neighbours: 4 drugs5 trials
Drawn: 9 of 9 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
BRCA Hereditary Ovarian Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Olaparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	BRCA Hereditary Ovarian Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants	—

BRCA Hereditary Ovarian Carcinoma studied in …STUDIED_INderived5 of 5
→ studied in	NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	BRCA Hereditary Ovarian Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04673448Phase 1 · active not recruiting Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 5 trials mapped (4 active)	—	—	BRCA Hereditary Ovarian Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03943173early Phase 1 · active not recruiting Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery · condition mapped ALIAS · 5 trials mapped (4 active)	—	—	BRCA Hereditary Ovarian Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04009148active not recruiting Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome · condition mapped ALIAS · 5 trials mapped (4 active)	—	—	BRCA Hereditary Ovarian Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06065059Phase 1/Phase 2 · terminated Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors · condition mapped ALIAS · 5 trials mapped (4 active)	—	—	BRCA Hereditary Ovarian Carcinoma	1	Observed	clinicaltrials	graph →